CoChat

Drug therapy in anticoagulation: which drug for which patient?

Open access
Millar, Carolyn M, Laffan, Mike A · 2017 · Clinical Medicine

The DOI matches its Crossref record, with a small difference in title or year; the references it cites are not checked yet.

Abstract

Four non-vitamin K oral anticoagulants (NOACs) are now licensed and available in the UK, offering unprecedented choices in anticoagulant therapy for clinicians and patients. NOACs have many clear benefits over warfarin, the most striking being the reduction in intracranial haemorrhage. However, a number of uncertainties remain: their efficacy in certain situations, utility of drug assays, significance of drug interactions and management of bleeding. In the absence of any direct comparative trials, it is not clear that any of the NOACs is significantly better than the others in any of the licensed indications. The differential activities, pharmacokinetics, metabolism, excretion and side effects of the agents should be considered when selecting the most appropriate anticoagulant. In this article, we discuss how, with careful selection for the relevant indication, NOACs can simplify therapy while improving outcomes. We aim to provide clinicians with the information needed to select the most suitable anticoagulant drug for an individual patient in a given situation.

Overview

Integrity signals

Registry

Crossref · 10.7861/clinmedicine.17-3-233

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 86 · Cited by 11

Metadata

Authors
Millar, C. M., & Laffan, M. A.
Affiliations
Imperial College Healthcare NHS Trust (GB)
Corresponding author
Millar, Carolyn M
Venue
Clinical Medicine
Publisher
Elsevier BV
Published
2017-06
Volume
17
Issue
3
Pages
233-244
ISSN
1470-2118 (ISSN-L)
OpenAlex
W2617874505
Cited by
11
References
86
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1
FWCI
1.27
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical Medicine (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • National Institute for Health and Care Research
  • Imperial College London
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
direct oral anticoagulants, anticoagulant selection, warfarin, intracranial hemorrhage, drug interactions, hemorrhage control, anticoagulation monitoring, pharmacokinetics, thromboprophylaxis
MeSH terms
Aged, Aged, 80 and over, Anticoagulants, Antithrombins, Atrial Fibrillation, Humans, Comorbidity, Factor Xa Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug therapy in anticoagulation: which drug for which patient? https://app.cochat.ai/papers/10.7861/clinmedicine.17-3-233
The paper
Millar, C. M., & Laffan, M. A. (2017). Drug therapy in anticoagulation: which drug for which patient? Clinical Medicine. https://doi.org/10.7861/clinmedicine.17-3-233

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.